A citation-based method for searching scientific literature

Xin Zhao, Xin Tian, Sachiko Kajigaya, Caroline R Cantilena, Stephen Strickland, Bipin N Savani, Sanjay Mohan, Xingmin Feng, Keyvan Keyvanfar, Neil Dunavin, Danielle M Townsley, Bogdan Dumitriu, Minoo Battiwalla, Katayoun Rezvani, Neal S Young, A John Barrett, Sawa Ito. Br J Haematol 2016
Times Cited: 15







List of co-cited articles
129 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
148
40

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
33

A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.
Pedro Castelo-Branco, Ricardo Leão, Tatiana Lipman, Brittany Campbell, Donghyun Lee, Aryeh Price, Cindy Zhang, Abolfazl Heidari, Derek Stephens, Stefan Boerno,[...]. Oncotarget 2016
37
33

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
33

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
26

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
273
26

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
172
26

DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
T R Devereux, I Horikawa, C H Anna, L A Annab, C A Afshari, J C Barrett. Cancer Res 1999
179
26

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Na Wang, Hanna Kjellin, Anastasios Sofiadis, Omid Fotouhi, C Christofer Juhlin, Martin Bäckdahl, Jan Zedenius, Dawei Xu, Janne Lehtiö, Catharina Larsson. Oncotarget 2016
29
26

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
Gina Fürtjes, Michaela Köchling, Susanne Peetz-Dienhart, Andrea Wagner, Katharina Heß, Martin Hasselblatt, Volker Senner, Walter Stummer, Werner Paulus, Benjamin Brokinkel. J Neurooncol 2016
20
26

Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population.
Hong Zhang, Xiaoling Weng, Junyi Ye, Lin He, Daizhan Zhou, Yun Liu. Clin Res Hepatol Gastroenterol 2015
24
26

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.
Ayalew Tefferi, Terra L Lasho, Kebede H Begna, Mrinal M Patnaik, Darci L Zblewski, Christy M Finke, Rebecca R Laborde, Emnet Wassie, Lauren Schimek, Curtis A Hanson,[...]. N Engl J Med 2015
197
20

Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.
Yiping Fan, Seungjae Lee, Gang Wu, John Easton, Donald Yergeau, Reinhard Dummer, Peter Vogel, John M Kirkwood, Raymond L Barnhill, Alberto Pappo,[...]. J Invest Dermatol 2016
26
20

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
515
20

Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma.
Jiaying Deng, Daizhan Zhou, Junhua Zhang, Yun Chen, Chunyu Wang, Yun Liu, Kuaile Zhao. Cancer Genet 2015
5
60

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Dong-Sheng Huang, Zhaohui Wang, Xu-Jun He, Bill H Diplas, Rui Yang, Patrick J Killela, Qun Meng, Zai-Yuan Ye, Wei Wang, Xiao-Ting Jiang,[...]. Eur J Cancer 2015
97
20

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.
S Renaud, D Loukinov, Z Abdullaev, I Guilleret, F T Bosman, V Lobanenkov, J Benhattar. Nucleic Acids Res 2007
134
20

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
190
20

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
854
20

Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.
Yongxin Wu, Guichao Li, Dong He, Fengping Yang, Guang He, Lin He, Hui Zhang, Yun Deng, Ming Fan, Lijun Shen,[...]. Onco Targets Ther 2016
10
30

Methylation of the human telomerase gene CpG island.
S K Dessain, H Yu, R R Reddel, R L Beijersbergen, R A Weinberg. Cancer Res 2000
146
20

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
Timothy J Ley, Christopher Miller, Li Ding, Benjamin J Raphael, Andrew J Mungall, A Gordon Robertson, Katherine Hoadley, Timothy J Triche, Peter W Laird, Jack D Baty,[...]. N Engl J Med 2013
20

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
Tamer E Fandy, James G Herman, Patrick Kerns, Anchalee Jiemjit, Elizabeth A Sugar, Si-Ho Choi, Allen S Yang, Timothy Aucott, Tianna Dauses, Rosalie Odchimar-Reissig,[...]. Blood 2009
212
20

Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma.
Brittani Seynnaeve, Seungjae Lee, Sumit Borah, Yongseok Park, Alberto Pappo, John M Kirkwood, Armita Bahrami. Sci Rep 2017
30
20

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
124
20


hTERT promoter methylation in pituitary adenomas.
Michaela Köchling, Christian Ewelt, Gina Fürtjes, Susanne Peetz-Dienhart, Björn Koos, Martin Hasselblatt, Werner Paulus, Walter Stummer, Benjamin Brokinkel. Brain Tumor Pathol 2016
13
23

Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
Satoru Kyo, Masahiro Takakura, Toshiyoshi Fujiwara, Masaki Inoue. Cancer Sci 2008
245
20



Human telomerase and its regulation.
Yu-Sheng Cong, Woodring E Wright, Jerry W Shay. Microbiol Mol Biol Rev 2002
590
20

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
144
20

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Donghyun D Lee, Ricardo Leão, Martin Komosa, Marco Gallo, Cindy H Zhang, Tatiana Lipman, Marc Remke, Abolfazl Heidari, Nuno Miguel Nunes, Joana D Apolónio,[...]. J Clin Invest 2019
47
20

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
74
20


Structure and function of telomeres.
E H Blackburn. Nature 1991
13

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).
Patrick A Thompson, Rachid Drissi, Jodi A Muscal, Eshini Panditharatna, Maryam Fouladi, Ashish M Ingle, Charlotte H Ahern, Joel M Reid, Tong Lin, Brenda J Weigel,[...]. Clin Cancer Res 2013
35
13

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
A A Chiappori, T Kolevska, D R Spigel, S Hager, M Rarick, S Gadgeel, N Blais, J Von Pawel, L Hart, M Reck,[...]. Ann Oncol 2015
86
13

hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
Jillian de Wilde, Jan M Kooter, Renée M Overmeer, Debbie Claassen-Kramer, Chris J L M Meijer, Peter J F Snijders, Renske D M Steenbergen. BMC Cancer 2010
43
13

hTERT methylation and expression in gastric cancer.
Carolina Oliveira Gigek, Mariana Ferreira Leal, Patricia Natalia Oliveira Silva, Luara Carolina Frias Lisboa, Eleonidas Moura Lima, Danielle Queiroz Calcagno, Paulo Pimentel Assumpção, Rommel Rodriguez Burbano, Marilia de Arruda Cardoso Smith. Biomarkers 2009
34
13

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
A Zhang, C Zheng, C Lindvall, M Hou, J Ekedahl, R Lewensohn, Z Yan, X Yang, M Henriksson, E Blennow,[...]. Cancer Res 2000
115
13


Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.
Inga Nagel, Monika Szczepanowski, José I Martín-Subero, Lana Harder, Takashi Akasaka, Ole Ammerpohl, Evelyne Callet-Bauchu, Randy D Gascoyne, Stefan Gesk, Doug Horsman,[...]. Blood 2010
32
13


Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value.
Vincent Ruland, Stefan Hartung, Uwe Kordes, Johannes E Wolff, Werner Paulus, Martin Hasselblatt. J Neurooncol 2014
7
28

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.
Guillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, Maria R Baer, Mikkael A Sekeres, Gail J Roboz, Gianluca Gaidano, Bart L Scott, Peter Greenberg, Uwe Platzbecker,[...]. Lancet Oncol 2016
93
13

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
H Yang, C Bueso-Ramos, C DiNardo, M R Estecio, M Davanlou, Q-R Geng, Z Fang, M Nguyen, S Pierce, Y Wei,[...]. Leukemia 2014
384
13

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List,[...]. Lancet Oncol 2009
13

Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41.
Ashley A Basiorka, Kathy L McGraw, Leentje De Ceuninck, Lori N Griner, Ling Zhang, Justine A Clark, Gisela Caceres, Lubomir Sokol, Rami S Komrokji, Gary W Reuther,[...]. Cancer Res 2016
19
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.